(7R)-2-[(3R)-3-methylmorpholin-4-yl]-7-propan-2-ylspiro[5,7-dihydropyrazolo[1,5-a]pyrazine-6,1'-cyclopropane]-4-one
C16H24N4O2 — CID 163276654
Data last refreshed: (MolForge compound catalog, from PubChem)
About (7R)-2-[(3R)-3-methylmorpholin-4-yl]-7-propan-2-ylspiro[5,7-dihydropyrazolo[1,5-a]pyrazine-6,1'-cyclopropane]-4-one
(7R)-2-[(3R)-3-methylmorpholin-4-yl]-7-propan-2-ylspiro[5,7-dihydropyrazolo[1,5-a]pyrazine-6,1'-cyclopropane]-4-one (PubChem CID 163276654) has the molecular formula C16H24N4O2 and a molecular weight of 304.39 g/mol. Its IUPAC name is (7R)-2-[(3R)-3-methylmorpholin-4-yl]-7-propan-2-ylspiro[5,7-dihydropyrazolo[1,5-a]pyrazine-6,1'-cyclopropane]-4-one.
Molecular Properties
| Compound Name | (7R)-2-[(3R)-3-methylmorpholin-4-yl]-7-propan-2-ylspiro[5,7-dihydropyrazolo[1,5-a]pyrazine-6,1'-cyclopropane]-4-one |
|---|---|
| PubChem CID | 163276654 |
| Molecular Formula | C16H24N4O2 |
| Molecular Weight | 304.39 g/mol |
| Exact Mass | 304.19 |
| IUPAC Name | (7R)-2-[(3R)-3-methylmorpholin-4-yl]-7-propan-2-ylspiro[5,7-dihydropyrazolo[1,5-a]pyrazine-6,1'-cyclopropane]-4-one |
| SMILES | CC(C)[C@H]1n2nc(N3CCOC[C@H]3C)cc2C(=O)NC12CC2 |
| InChI | InChI=1S/C16H24N4O2/c1-10(2)14-16(4-5-16)17-15(21)12-8-13(18-20(12)14)19-6-7-22-9-11(19)3/h8,10-11,14H,4-7,9H2,1-3H3,(H,17,21)/t11-,14-/m1/s1 |
| InChIKey | BOUSJPKIEBGQER-BXUZGUMPSA-N |
| XLogP | 1.58 |
| TPSA | 59.39 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 2 |
| Heavy Atoms | 22 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 304.39 |
| LogP ≤ 5 | 1.58 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 163276654 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.